In REGENXBIO Inc. v. Sarepta Therapeutics, Inc., Regenxbio, company developing gene therapy, sued Sarepta for infringement of claims of U.S. Pat. No. 105526417.
Einstein's aphorism that doing the same thing over and over again and expecting a different outcome is a hallmark of madness (or at least an inability to learn from the past) inevitably.
Last week, IP Law360 published an erudite and provocative article by Joseph Matal and his colleagues regarding the Supreme Court's recent subject matter jurisprudence in the context of.